Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

81-13-0

D-Panthenol / Dexpanthenol

81-13-0
5629-60-7

Pteropodine UNCARINE C(P)

5629-60-7
78822-40-9

Pirlimycin HCl

78822-40-9
24634-61-5

Potassium Sorbate

24634-61-5
53-03-2

Prednisone

53-03-2
229-87-8

Phenanthridine

229-87-8
110-86-1

Pyridine

110-86-1
09/11/4135

Polymyxin B1 Sulfate

09/11/4135
33818-15-4

Citicoline monosodique

33818-15-4
168088-61-7

Pyribenzoxim

168088-61-7
49656-78-2

2-(Methylamino)propiophenone hydrochloride

49656-78-2
22374-89-6

3-Amino-1-phenylbutane

22374-89-6
98-80-6

Phenylboronic acid

98-80-6
93-55-0

Propiophenone

93-55-0
79-50-5

DL-Pantolactone

79-50-5
3777-69-3

Pentylfuran-2

3777-69-3
84-11-7

Phenanthrenequinone-9,10

84-11-7
66258-76-2

Piperacillin

66258-76-2
85-73-4

Phthalylsulfathiazole

85-73-4
20170-32-5

3-(3,5-Di-t-butyl-4-OH-phenyl)propionic Ac

20170-32-5